PE20010941A1 - Uso de agonistas de prostaglandinas para tratar la disfuncion erectil o la impotencia - Google Patents
Uso de agonistas de prostaglandinas para tratar la disfuncion erectil o la impotenciaInfo
- Publication number
- PE20010941A1 PE20010941A1 PE2000001279A PE0012792000A PE20010941A1 PE 20010941 A1 PE20010941 A1 PE 20010941A1 PE 2000001279 A PE2000001279 A PE 2000001279A PE 0012792000 A PE0012792000 A PE 0012792000A PE 20010941 A1 PE20010941 A1 PE 20010941A1
- Authority
- PE
- Peru
- Prior art keywords
- alkylene
- members
- ring
- erectile dysfunction
- impotence
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16851999P | 1999-12-02 | 1999-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010941A1 true PE20010941A1 (es) | 2001-09-24 |
Family
ID=22611826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001279A PE20010941A1 (es) | 1999-12-02 | 2000-11-30 | Uso de agonistas de prostaglandinas para tratar la disfuncion erectil o la impotencia |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1108426A3 (enExample) |
| JP (1) | JP2001163779A (enExample) |
| KR (1) | KR20010062061A (enExample) |
| AU (1) | AU7193400A (enExample) |
| CA (1) | CA2327164A1 (enExample) |
| CO (1) | CO5271724A1 (enExample) |
| HU (1) | HUP0004780A3 (enExample) |
| IL (1) | IL139941A0 (enExample) |
| NZ (1) | NZ508560A (enExample) |
| PE (1) | PE20010941A1 (enExample) |
| ZA (1) | ZA200007019B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1002847B (el) | 1997-05-06 | 1998-01-27 | Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως | |
| GR1003199B (el) | 1998-08-14 | 1999-09-01 | Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες | |
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| EP1661580B1 (en) | 2003-07-25 | 2014-01-08 | Ono Pharmaceutical Co., Ltd. | Remedy for cartilage-related diseases |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
| DK1848430T3 (da) | 2004-12-31 | 2017-11-06 | Dr Reddys Laboratories Ltd | Nye benzylamin-derivativer som cetp-inhibitors |
| ATE465986T1 (de) | 2005-01-14 | 2010-05-15 | Allergan Inc | Substituierte cyclopentane oder cyclopentanone zur behandlung von augenhochdruck |
| US7323591B2 (en) | 2006-01-10 | 2008-01-29 | Allergan, Inc. | Substituted cyclopentanes or cyclopentanones as therapeutic agents |
| BRPI0713587A2 (pt) | 2006-06-20 | 2012-10-23 | Allergan Inc | descrição de compostos terapêuticos da invenção |
| AU2007272683B2 (en) * | 2006-07-10 | 2012-08-23 | Allergan, Inc. | Substituted cyclopentane derivatives as therapeutic agents |
| NZ573964A (en) | 2006-07-28 | 2010-11-26 | Pfizer Prod Inc | isopropyl [3-({[4-(1H-pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)-amino}methyl)phenoxy]acetate, a prostaglandin E2 receptor agonist (EP2), useful in lower intraocular pressure thereby treating glaucoma |
| JP5453254B2 (ja) | 2007-07-03 | 2014-03-26 | アラーガン インコーポレイテッド | 眼圧降下用の治療用置換シクロペンタン類 |
| US8592413B2 (en) | 2008-05-15 | 2013-11-26 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| WO2010116270A1 (en) | 2009-04-10 | 2010-10-14 | Pfizer Inc. | Ep2/4 agonists |
| CA2845284C (en) | 2011-08-18 | 2018-03-06 | Dr. Reddy's Laboratories Ltd. | Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (cetp) inhibitors |
| JP6140168B2 (ja) | 2011-09-27 | 2017-05-31 | ドクター レディズ ラボラトリーズ リミテッド | アテローム性動脈硬化症の処置のために有用なコレステリルエステル転送タンパク質（ｃｅｔｐ）インヒビターとしての５−ベンジルアミノメチル−６−アミノピラゾロ［３，４−ｂ］ピリジン誘導体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA59384C2 (uk) * | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
| SE9702681D0 (sv) * | 1997-07-10 | 1997-07-10 | Pharmacia & Upjohn Ab | Method and composition for treatment of impotence |
-
2000
- 2000-11-27 EP EP00310511A patent/EP1108426A3/en not_active Withdrawn
- 2000-11-27 IL IL13994100A patent/IL139941A0/xx unknown
- 2000-11-29 ZA ZA200007019A patent/ZA200007019B/xx unknown
- 2000-11-30 CA CA002327164A patent/CA2327164A1/en not_active Abandoned
- 2000-11-30 JP JP2000364643A patent/JP2001163779A/ja active Pending
- 2000-11-30 AU AU71934/00A patent/AU7193400A/en not_active Abandoned
- 2000-11-30 PE PE2000001279A patent/PE20010941A1/es not_active Application Discontinuation
- 2000-12-01 NZ NZ508560A patent/NZ508560A/xx unknown
- 2000-12-01 KR KR1020000072390A patent/KR20010062061A/ko not_active Ceased
- 2000-12-01 HU HU0004780A patent/HUP0004780A3/hu unknown
- 2000-12-04 CO CO00092096A patent/CO5271724A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001163779A (ja) | 2001-06-19 |
| KR20010062061A (ko) | 2001-07-07 |
| AU7193400A (en) | 2001-06-07 |
| HUP0004780A3 (en) | 2004-06-28 |
| EP1108426A2 (en) | 2001-06-20 |
| EP1108426A3 (en) | 2002-10-02 |
| CA2327164A1 (en) | 2001-06-02 |
| NZ508560A (en) | 2002-11-26 |
| ZA200007019B (en) | 2002-05-29 |
| IL139941A0 (en) | 2002-02-10 |
| HU0004780D0 (enExample) | 2001-02-28 |
| HUP0004780A2 (hu) | 2002-04-29 |
| CO5271724A1 (es) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9303213A (es) | Derivados de acido ditiofosforico como aditivos lubricantes. | |
| DK0889876T3 (da) | Meta-substituerede phenylensulfonamidderivater | |
| ATE306261T1 (de) | Antithrombosemittel | |
| DK1249461T3 (da) | Syreblokerede aminkatalysatorer til fremstilling af polyurethaner | |
| ATE297203T1 (de) | Antithrombotische mitteln | |
| BG105457A (en) | Method for the preparation of citalopram | |
| GB0216539D0 (en) | Compositions | |
| PT753301E (pt) | Combinacao de um benzimidazole tendo actividade antagonista da angiotensina ii com um diuretico | |
| ATE291021T1 (de) | Oxytocin agonisten | |
| BR0109048A (pt) | Processo para a sìntese de citalopram | |
| ATE270271T1 (de) | Sulfonamidhydroxamate | |
| EA200000431A3 (ru) | Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их | |
| ES2166928T3 (es) | Derivados de ciclopentanbutanol como odorantes. | |
| ES8602816A1 (es) | Un procedimiento para la preparacion de nuevos antibioticos de cefalosporina. | |
| ES2106936T5 (es) | Derivados de carbazolona y procedimientos para su preparacion. | |
| EA200101234A1 (ru) | Новые производные аминотиазола, их получение и содержащие их фармацевтические композиции | |
| AR005532A1 (es) | Compuestos de dihalopropeno, las composiciones insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos | |
| AR027559A1 (es) | Metodo para la preparacion de citalopram | |
| PT763024E (pt) | Novos processos e intermediarios para a preparacao de derivados de piperazina | |
| AR020520A1 (es) | Metodo para el uso de diesteres de acidos carboxilicos alifaticos como herbicidas no selectivos | |
| EA200200807A1 (ru) | Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece | |
| EA199901050A2 (ru) | Новые соединения имидазолина, способ их получения и содержащие их фармацевтические композиции | |
| AR006809A1 (es) | Compuestos de sulfonilurea de formula i, una composicion herbicida e inhibidora de crecimiento de las plantas, un metodo para combatir el desarrollode plantas perjudiciales, el uso de una composicion, un metodo paraaumentar la estabilidad en el almacenamiento de las composiciones herbidcidase inhibidoras | |
| BR9711948A (pt) | Composto processo para produzir um composto composi-Æo farmac-utica e uso de um composto | |
| EA200000929A2 (ru) | Новые цианоиндольные соединения-ингибиторы повторного захвата серотонина, способ их получения и содержащие их фармацевтические композиции |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |